LONDON STOCK EXCHANGE · AZN

+0.86% · +$1.50 · Vol 1.5M

AstraZeneca PLC

Pharmaceuticals

$176.43

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

REFRESHES DAILY

AI Analysis

Sovereign

Why is AZN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

About AstraZeneca PLC

Pharmaceuticals

Listed since

2009

Employees

96K

Country

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$175.29

Day high

$177.43

Day low

$175.11

Previous close

$174.93

52W high

$181.73

-2.92% from high

52W low

$174.93

22% of range

Market cap

$271.3B

P/E

26.15×

EPS

$6.65

Shares out

1.6B

Volume

1.5M

VWAP

$176.36

Price history computed in-house

-1.21%

SMA 50 $178.47 · below

SMA 200 $178.47 · below

52W position 22%

Veridion warehouse edge

Warehouse intelligence for AZN.

Veridion Score

0: 591: 522: 473: 504: 795: 90

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

AZN insider activity

AstraZeneca PLC

Score

Coverage building

Pressure

Net selling

Filings

Buys / sells

1 / 1

Net value

-$2.2M

Insiders

Named filers

Sharma Mani

Insider

Leadership

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$2.2M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-06-16	2026-06-08	Sharma Mani	Insider	buy	$179.75	1	19,263	$180	SEC Form 4
2026-05-22	2026-05-20	Sharma Mani	Insider	sell	$185.78	11,893	19,262	$2.2M	SEC Form 4

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

AZN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for AZN in this window.

Lobbying spend

AZN lobbying filings, year to date.

Registered lobbying filings matched to AstraZeneca PLC.

$3.2M

Refresh interval: 12hSource: LDA disclosure filings

Budget/Appropriations Medicare/Medicaid Health IssuesHealth Issues Medicare/MedicaidHealth Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)

Filing

$2.3M

ASTRAZENECA PHARMACEUTICALS LP

Apr 20, 2026

Filing

$670.0K

ASTRAZENECA PHARMACEUTICALS LP

Jan 20, 2026

Filing

$90.0K

ASTRAZENECA

TIBER CREEK GROUP